Latest News

Filters

Filter by tags: Europe Medicine Clear all tag filters

7 news articles found

Russia's Ministry of Industry and Trade, representatives from the Kaluga region and the city of Obninsk, and Rosatom have signed a special investment contract for the construction of what Rosatom says will be Europe's largest plant for the production of radiopharmaceuticals.

Source: World Nuclear News
Date: Wednesday, 11 October 2023
Original article: world-nuclear-news.org/Articles/Special-investment-contract-signed-for-Russian-med

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Source: Nucnet
Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

The aim is to have production lines operating at the plant in Obninsk by 2025, supplying products for the diagnosis and treatment of patients, including a wide range of cancers. Rosatom says it will ensure Russia's sovereignty in the production of radiopharmaceuticals.

Source: World Nuclear News
Date: Wednesday, 25 January 2023
Original article: world-nuclear-news.org/Articles/Construction-starts-for-Russian-medical-isotopes-p

The nuclear medicine sector is a small part of the wider nuclear industry, but it provides some of the most pioneering technologies in healthcare - and is close to making personalised medicine a reality. Antonis Kalemis, president of Nuclear Medicine Europe and business manager for molecular imaging at Siemens Healthineers, describes how nuclear medicine also tackles the most trenchant condition in modern healthcare: cancer.

Source: World Nuclear News
Date: Thursday, 29 July 2021
Original article: world-nuclear-news.org/Articles/Viewpoint-Nuclear-medicine-is-crucial-for-fighting

Radioisotopes essential for diagnostics and treatment of severe diseases Brussels-based nuclear industry association Foratom has called on the European Union to better recognise and support the medical applications of nuclear technology, which play a significant role in the medical sector and help “save thousands of lives each day.”

Foratom said in a joint position paper with Nuclear Medicine Europe that EU policy makers should find ways of promoting new research reactor capacity along with innovation in the sector, and implement a number of recommendations to maintain the current level of medical radioisotopes supply.

According to the paper, in order to ensure that the supply of medical radioisotopes will be continued, the EU needs to develop a “robust” supply chain which goes beyond irradiation, adapt clinical research and development of new radiopharmaceutical compounds, and reconsider reimbursement systems for radiopharmaceutical products.

Source: Nucnet
Date: Wednesday, 16 June 2021
Original article: nucnet.org/news/foratom-urges-european-union-to-provide-more-support-for-nuclear-medicine-6-2-2021

Europe must take action to maintain the current level of medical radioisotopes supply, according to a joint position paper from Foratom, the European nuclear trade body, and Nuclear Medicine Europe, which represents pharmaceutical and imaging equipment companies in the field of nuclear medicine. They say the European Union should promote new research reactor capacity along with innovation in the sector and the design modification of the current fleet.

Source: World Nuclear News
Date: Wednesday, 16 June 2021
Original article: world-nuclear-news.org/Articles/EU-industry-bodies-call-for-more-support-for-nucle

Thirty-five years on from the Chernobyl accident, Ukraine and the International Atomic Energy Agency (IAEA) have highlighted their commitment to cooperation in nuclear power. Meanwhile Ukraine’s nuclear regulator has launched the start of operations at a new storage facility for used nuclear fuel at the Chernobyl site.  

Source: World Nuclear News
Date: Wednesday, 28 April 2021
Original article: world-nuclear-news.org/Articles/Title